FDA Clears Ultherapy PRIME for Skin Laxity on the Knees
The FDA has cleared Merz Aesthetics’ Ultherapy PRIME to improve the appearance of skin laxity on the knees, expanding the device’s body indications.
The FDA has cleared Merz Aesthetics’ Ultherapy PRIME to improve the appearance of skin laxity on the knees, expanding the device’s body indications.
New sizes for the Mia and Preserve systems expand the company’s minimally invasive breast offerings. The company also presented new clinical data on breast tissue preservation to more than 1,000 plastic surgeons.